SlideShare une entreprise Scribd logo
1  sur  10
FDA Notificationsand Medwatch Form Requirements
Adverse Event Reporting for
OTC Drugs and Dietary
Supplements
The Background– What YouNeedto Know
Adverse Event (AE) reporting
regulations implement the Dietary
Supplement & OTC Drug
Consumer Protection Act of 2006
(Public Law 109-462).
FDA regulations for adverse
event reporting went into effect in
December 2007. Product label
must contain the address (street
address or P.O. Box) or phone
number at which company or
other responsible person will
receive a serious adverse event
report.
Serious Adverse Event (SAE)
reporting is required for all OTC
Drugs and Dietary
Supplements.
Products That Are Covered
All OTC monographed drugs (Rx to
OTC drugs are already required to
report AEs).
All dietary supplements including
vitamins, minerals, herbal or other
botanical products, amino acids, or
any dietary substance used to
supplement the diet by increasing the
total dietary intake.
When the Personal Care Products
Safety Act becomes law, cosmetics will
also be covered.
Death: Report if the
patient’s death is
suspected of being
associated with use of
the product by the
patient.
Life-Threatening: Report
if the person was at
substantial risk of dying
at time of the adverse
event or if suspected
that continued use of
product could result in a
person’s death.
Hospitalization: Report if
admission to the hospital
was caused by or related
to an adverse event
associated with use of
the product. Emergency
Room treatment is
sometimes reported too.
Disability: Report if the
adverse event resulted in
a significant or
permanent change,
impairment or damage
to the person’s body
function/structure or
quality of life.
Spontaneous abortion,
congenital anomaly or
birth defect associated
with a product use must
also be reported to the
FDA.
Definition of a Serious Adverse Event (SAE)
Section 761(a)(2) of the F,D, & C Act
FDA Notifications- Voluntary SAE Reporting
FDA encourages healthcare
professionals to report serious
adverse events to the agency
for tracking purposes.
FDA’s Center for Food Safety &
Applied Nutrition (CFSAN)
Adverse Event Reporting
System (CAERS) collects reports
about adverse events and
product complaints related to
CFSAN regulated products,
including foods, dietary
supplements and cosmetics.
CFSAN encourages voluntary AE
reports for cosmetics and
conventional foods.
If a company receives a report
of a serious adverse event, you
should report it to CAERS even
if reporting isn’t mandatory for
the product (e.g. a food or
cosmetic).
FDA Notifications
Many serious adverse
events are reported to FDA
directly by consumers,
hospitals, or healthcare
professionals.
If FDA receives a serious
adverse event report about
a company’s product they
will contact you and you
must keep that report on
file. Often FDA notification
comes with a request for
more information and
submission of a Medwatch
form with product label.
MedwatchFormRequirements(Form 3500A)
Medwatch form must identify the injured person (name, age, sex, full address, etc.). Initials
are used to protect privacy.
An identifiable initial reporter of the event.
Identity and contact information for the responsible party (i.e. the manufacturer, packer,
or distributor representative submitting the AE report to FDA).
Name of the specific product that is suspected of causing the adverse event (not just a
brand name).
Description of the serious adverse event with outcome.
Address for MedwatchFormHard Copy
Submission
DIETARY SUPPLEMENTS: FAX NUMBER FOR ALL AEs:
1 800 332 - 0178
FDA Center Food Safety & Nutrition
Office of Food Defense, HFS -11
5100 Paint Brach Parkway
College Park, MD. 20740
OTC DRUGS:
FDA Center Drug Evaluation & Research
Central Document Room
5901-B Ammendale Road
Beltsville, MD. 20705-1266
Online Reportingof MedwatchForms
Or http://www.fda.gov/Safety/MedWatch/default.htm
Go to the FDA
website
(www.fda.gov), click
on “Drugs” and enter
“MEDWATCH form”.
Click on “Download
form” or click on
“Recalls & Alerts”
and see bullet called
“MEDWATCH.”
Click on “Report
serious adverse
events online.”
Thank You
Fororganizationaltrainingonadverseevent
reportingandFDA compliance,visit
www.complianceonline.com.

Contenu connexe

Tendances

ICH E2A GUIDELINE
ICH E2A GUIDELINEICH E2A GUIDELINE
ICH E2A GUIDELINEsathishat9
 
ICSR Workflow & Management_Katalyst HLS
ICSR Workflow & Management_Katalyst HLSICSR Workflow & Management_Katalyst HLS
ICSR Workflow & Management_Katalyst HLSKatalyst HLS
 
Post Marketing Drug Safety & Pharmacovigilance
Post Marketing Drug Safety & PharmacovigilancePost Marketing Drug Safety & Pharmacovigilance
Post Marketing Drug Safety & PharmacovigilanceMd. Zakaria Faruki
 
Post marketing surveilance
Post marketing surveilancePost marketing surveilance
Post marketing surveilanceaiswarya thomas
 
Fundamentals of Pharmacovigilance
Fundamentals of PharmacovigilanceFundamentals of Pharmacovigilance
Fundamentals of PharmacovigilanceAnindya Banerjee
 
Reporting Methods _ Global Pharmacovigilance1
Reporting Methods _ Global Pharmacovigilance1Reporting Methods _ Global Pharmacovigilance1
Reporting Methods _ Global Pharmacovigilance1Hafsa Hafeez
 
Pharmacovigilance Practice In
Pharmacovigilance Practice InPharmacovigilance Practice In
Pharmacovigilance Practice Inclarityeye
 
Pharmacovigilance overview
Pharmacovigilance overviewPharmacovigilance overview
Pharmacovigilance overviewAcri India
 
Clinical research and pharmacovigilance biopharmaceutics
Clinical research and pharmacovigilance biopharmaceuticsClinical research and pharmacovigilance biopharmaceutics
Clinical research and pharmacovigilance biopharmaceuticsPrajith V
 
Pharmacovigilance Training in Oracle Argus Safety Database
Pharmacovigilance Training in Oracle Argus Safety DatabasePharmacovigilance Training in Oracle Argus Safety Database
Pharmacovigilance Training in Oracle Argus Safety DatabaseGratisol Labs
 
importance of pharmcovigilance
importance of pharmcovigilanceimportance of pharmcovigilance
importance of pharmcovigilancesiddemsetty nikhil
 
Literature surveillance in pharmacovigilance
Literature surveillance in pharmacovigilanceLiterature surveillance in pharmacovigilance
Literature surveillance in pharmacovigilanceAnn-Marie Roche
 

Tendances (20)

ICH E2A GUIDELINE
ICH E2A GUIDELINEICH E2A GUIDELINE
ICH E2A GUIDELINE
 
ICSR Workflow & Management_Katalyst HLS
ICSR Workflow & Management_Katalyst HLSICSR Workflow & Management_Katalyst HLS
ICSR Workflow & Management_Katalyst HLS
 
Drug Safety and Pharmacovigilance - Need for internationally harmonized pape...
Drug Safety and Pharmacovigilance  - Need for internationally harmonized pape...Drug Safety and Pharmacovigilance  - Need for internationally harmonized pape...
Drug Safety and Pharmacovigilance - Need for internationally harmonized pape...
 
Post Marketing Drug Safety & Pharmacovigilance
Post Marketing Drug Safety & PharmacovigilancePost Marketing Drug Safety & Pharmacovigilance
Post Marketing Drug Safety & Pharmacovigilance
 
Pharmacovigilance
PharmacovigilancePharmacovigilance
Pharmacovigilance
 
Fda guidance for pharmaceutical post marketing reporting professor pirouzi
Fda guidance for pharmaceutical post marketing reporting   professor pirouziFda guidance for pharmaceutical post marketing reporting   professor pirouzi
Fda guidance for pharmaceutical post marketing reporting professor pirouzi
 
Post marketing surveilance
Post marketing surveilancePost marketing surveilance
Post marketing surveilance
 
Introduction to post marketing drug safety surveillance fda 2-11-14
Introduction to post marketing drug safety surveillance fda 2-11-14Introduction to post marketing drug safety surveillance fda 2-11-14
Introduction to post marketing drug safety surveillance fda 2-11-14
 
Fundamentals of Pharmacovigilance
Fundamentals of PharmacovigilanceFundamentals of Pharmacovigilance
Fundamentals of Pharmacovigilance
 
Reporting Methods _ Global Pharmacovigilance1
Reporting Methods _ Global Pharmacovigilance1Reporting Methods _ Global Pharmacovigilance1
Reporting Methods _ Global Pharmacovigilance1
 
Pharmacovigilance Practice In
Pharmacovigilance Practice InPharmacovigilance Practice In
Pharmacovigilance Practice In
 
Pharmacovigilance overview
Pharmacovigilance overviewPharmacovigilance overview
Pharmacovigilance overview
 
Vaishali chadha
Vaishali chadhaVaishali chadha
Vaishali chadha
 
Clinical research and pharmacovigilance biopharmaceutics
Clinical research and pharmacovigilance biopharmaceuticsClinical research and pharmacovigilance biopharmaceutics
Clinical research and pharmacovigilance biopharmaceutics
 
Pharmacovigilance Training in Oracle Argus Safety Database
Pharmacovigilance Training in Oracle Argus Safety DatabasePharmacovigilance Training in Oracle Argus Safety Database
Pharmacovigilance Training in Oracle Argus Safety Database
 
Ae ppt
Ae pptAe ppt
Ae ppt
 
importance of pharmcovigilance
importance of pharmcovigilanceimportance of pharmcovigilance
importance of pharmcovigilance
 
Pharmacovigilance and adr
Pharmacovigilance and adrPharmacovigilance and adr
Pharmacovigilance and adr
 
Literature surveillance in pharmacovigilance
Literature surveillance in pharmacovigilanceLiterature surveillance in pharmacovigilance
Literature surveillance in pharmacovigilance
 
Pharmacovigilance
PharmacovigilancePharmacovigilance
Pharmacovigilance
 

En vedette

FDA 2013 Clinical Investigator Training Course: Safety Assessment in Clinical...
FDA 2013 Clinical Investigator Training Course: Safety Assessment in Clinical...FDA 2013 Clinical Investigator Training Course: Safety Assessment in Clinical...
FDA 2013 Clinical Investigator Training Course: Safety Assessment in Clinical...MedicReS
 
510K Table of Contents - Medical Device Description
510K Table of Contents - Medical Device Description510K Table of Contents - Medical Device Description
510K Table of Contents - Medical Device Descriptioncomplianceonline123
 
Understanding FDA Requirements Medical Devices
Understanding FDA Requirements Medical DevicesUnderstanding FDA Requirements Medical Devices
Understanding FDA Requirements Medical Devicesmarchell
 
IVT 2016 June - Stat Tools Binary Data
IVT 2016 June - Stat Tools Binary DataIVT 2016 June - Stat Tools Binary Data
IVT 2016 June - Stat Tools Binary DataRaul Soto
 
ADVERSE EVENT PPT ATUL
ADVERSE EVENT PPT ATULADVERSE EVENT PPT ATUL
ADVERSE EVENT PPT ATULAtul Gupta
 
Webinar or Online Training on A comprehensive overview of 510(k) submission
Webinar or Online Training on A comprehensive overview of 510(k) submissionWebinar or Online Training on A comprehensive overview of 510(k) submission
Webinar or Online Training on A comprehensive overview of 510(k) submissionComplianz World
 
Information Required in a 510(k) Submission
Information Required in a 510(k) SubmissionInformation Required in a 510(k) Submission
Information Required in a 510(k) Submissioncomplianceonline123
 
FDA 510(k) Submission Tips & Best Practices
FDA 510(k) Submission Tips & Best PracticesFDA 510(k) Submission Tips & Best Practices
FDA 510(k) Submission Tips & Best PracticesGreenlight Guru
 
Excel spreadsheets how to ensure 21 cfr part 11 compliance
Excel spreadsheets  how to ensure 21 cfr part 11 complianceExcel spreadsheets  how to ensure 21 cfr part 11 compliance
Excel spreadsheets how to ensure 21 cfr part 11 compliancecomplianceonline123
 
Medical Device Reporting 3-6-15
Medical Device Reporting    3-6-15Medical Device Reporting    3-6-15
Medical Device Reporting 3-6-15John Arndts
 
Clinipace worldwide: Conducting Clinical Trials in Latin America
Clinipace worldwide: Conducting Clinical Trials in Latin AmericaClinipace worldwide: Conducting Clinical Trials in Latin America
Clinipace worldwide: Conducting Clinical Trials in Latin Americaguestc74e8c36
 
Latin America: Challenges & Opportunities in Clinical Research
Latin America: Challenges & Opportunities in Clinical ResearchLatin America: Challenges & Opportunities in Clinical Research
Latin America: Challenges & Opportunities in Clinical ResearchMedpace
 
Clinical Trials Latin America Oct 2010 1
Clinical Trials Latin America Oct 2010 1Clinical Trials Latin America Oct 2010 1
Clinical Trials Latin America Oct 2010 1poli990
 
Netherland medical devices compliance update
Netherland medical devices compliance update Netherland medical devices compliance update
Netherland medical devices compliance update Erik Vollebregt
 
Clinical research in Latin America: constraints and opportunities
Clinical research in Latin America: constraints and opportunitiesClinical research in Latin America: constraints and opportunities
Clinical research in Latin America: constraints and opportunitiesCER Clinical Trials
 
Medical Device - ANVISA regulation in Brazil
Medical Device - ANVISA regulation in BrazilMedical Device - ANVISA regulation in Brazil
Medical Device - ANVISA regulation in BrazilSagi Grinshtein
 
Medical device regulations 510k
Medical device regulations 510kMedical device regulations 510k
Medical device regulations 510kSigma
 
Taiwan medical device registration and approval chart - EMERGO
Taiwan medical device registration and approval chart - EMERGOTaiwan medical device registration and approval chart - EMERGO
Taiwan medical device registration and approval chart - EMERGOEMERGO
 

En vedette (20)

FDA 2013 Clinical Investigator Training Course: Safety Assessment in Clinical...
FDA 2013 Clinical Investigator Training Course: Safety Assessment in Clinical...FDA 2013 Clinical Investigator Training Course: Safety Assessment in Clinical...
FDA 2013 Clinical Investigator Training Course: Safety Assessment in Clinical...
 
510K Table of Contents - Medical Device Description
510K Table of Contents - Medical Device Description510K Table of Contents - Medical Device Description
510K Table of Contents - Medical Device Description
 
Understanding FDA Requirements Medical Devices
Understanding FDA Requirements Medical DevicesUnderstanding FDA Requirements Medical Devices
Understanding FDA Requirements Medical Devices
 
IVT 2016 June - Stat Tools Binary Data
IVT 2016 June - Stat Tools Binary DataIVT 2016 June - Stat Tools Binary Data
IVT 2016 June - Stat Tools Binary Data
 
ADVERSE EVENT PPT ATUL
ADVERSE EVENT PPT ATULADVERSE EVENT PPT ATUL
ADVERSE EVENT PPT ATUL
 
Webinar or Online Training on A comprehensive overview of 510(k) submission
Webinar or Online Training on A comprehensive overview of 510(k) submissionWebinar or Online Training on A comprehensive overview of 510(k) submission
Webinar or Online Training on A comprehensive overview of 510(k) submission
 
Information Required in a 510(k) Submission
Information Required in a 510(k) SubmissionInformation Required in a 510(k) Submission
Information Required in a 510(k) Submission
 
Medical Device Regulations - 510(k) Process
Medical Device Regulations - 510(k) ProcessMedical Device Regulations - 510(k) Process
Medical Device Regulations - 510(k) Process
 
FDA 510(k) Submission Tips & Best Practices
FDA 510(k) Submission Tips & Best PracticesFDA 510(k) Submission Tips & Best Practices
FDA 510(k) Submission Tips & Best Practices
 
Excel spreadsheets how to ensure 21 cfr part 11 compliance
Excel spreadsheets  how to ensure 21 cfr part 11 complianceExcel spreadsheets  how to ensure 21 cfr part 11 compliance
Excel spreadsheets how to ensure 21 cfr part 11 compliance
 
Medical Device Reporting 3-6-15
Medical Device Reporting    3-6-15Medical Device Reporting    3-6-15
Medical Device Reporting 3-6-15
 
Clinipace worldwide: Conducting Clinical Trials in Latin America
Clinipace worldwide: Conducting Clinical Trials in Latin AmericaClinipace worldwide: Conducting Clinical Trials in Latin America
Clinipace worldwide: Conducting Clinical Trials in Latin America
 
Latin America: Challenges & Opportunities in Clinical Research
Latin America: Challenges & Opportunities in Clinical ResearchLatin America: Challenges & Opportunities in Clinical Research
Latin America: Challenges & Opportunities in Clinical Research
 
Clinical Trials Latin America Oct 2010 1
Clinical Trials Latin America Oct 2010 1Clinical Trials Latin America Oct 2010 1
Clinical Trials Latin America Oct 2010 1
 
Netherland medical devices compliance update
Netherland medical devices compliance update Netherland medical devices compliance update
Netherland medical devices compliance update
 
Clinical research in Latin America: constraints and opportunities
Clinical research in Latin America: constraints and opportunitiesClinical research in Latin America: constraints and opportunities
Clinical research in Latin America: constraints and opportunities
 
Medical Device - ANVISA regulation in Brazil
Medical Device - ANVISA regulation in BrazilMedical Device - ANVISA regulation in Brazil
Medical Device - ANVISA regulation in Brazil
 
Medical device regulations 510k
Medical device regulations 510kMedical device regulations 510k
Medical device regulations 510k
 
Clinical Trials In Latin America
Clinical Trials In Latin America Clinical Trials In Latin America
Clinical Trials In Latin America
 
Taiwan medical device registration and approval chart - EMERGO
Taiwan medical device registration and approval chart - EMERGOTaiwan medical device registration and approval chart - EMERGO
Taiwan medical device registration and approval chart - EMERGO
 

Similaire à Fda adverse event reporting requirements for otc drugs

Fda med watch
Fda med watchFda med watch
Fda med watchSridhar S
 
Reporting adverse events under COVID-19 to FDA
Reporting adverse events under COVID-19 to FDAReporting adverse events under COVID-19 to FDA
Reporting adverse events under COVID-19 to FDAChristine Zomorodian
 
Ceuta Pharmacovigilance Presentation 2014
Ceuta Pharmacovigilance Presentation 2014Ceuta Pharmacovigilance Presentation 2014
Ceuta Pharmacovigilance Presentation 2014Ceuta Healthcare
 
Pharma Uptoday Monthly Magazine - Volume 11, Issue Feb 2015
Pharma Uptoday Monthly Magazine - Volume 11, Issue Feb 2015Pharma Uptoday Monthly Magazine - Volume 11, Issue Feb 2015
Pharma Uptoday Monthly Magazine - Volume 11, Issue Feb 2015Sathish Vemula
 
How FSMA Changes The Status Quo For Food Businesses
How FSMA Changes The Status Quo For Food BusinessesHow FSMA Changes The Status Quo For Food Businesses
How FSMA Changes The Status Quo For Food Businesseskmodza
 
Pharmaceutical product recall
Pharmaceutical product recallPharmaceutical product recall
Pharmaceutical product recallPrandeep Borah
 
Ppt 1 overview of regulatory affairs and diff bodies_august2016_final
Ppt 1 overview of regulatory affairs and diff bodies_august2016_finalPpt 1 overview of regulatory affairs and diff bodies_august2016_final
Ppt 1 overview of regulatory affairs and diff bodies_august2016_finalRajashri Survase Ojha
 
My Presentation on Mexico Medical Device Regulations
My Presentation on Mexico Medical Device RegulationsMy Presentation on Mexico Medical Device Regulations
My Presentation on Mexico Medical Device RegulationsHarshit Thakkar
 
Labelling of drugs cosmetics nd biotech
Labelling of drugs cosmetics nd biotechLabelling of drugs cosmetics nd biotech
Labelling of drugs cosmetics nd biotechBindu Kshtriya
 
Pharmacovigilance sytem in United States of America (USA)
Pharmacovigilance sytem in United States of America (USA)Pharmacovigilance sytem in United States of America (USA)
Pharmacovigilance sytem in United States of America (USA)PharmXL International Pvt. Ltd.
 
Pharma Uptoday Monthly Magazine Volume 5, Issue Aug 2014
Pharma Uptoday Monthly Magazine Volume 5, Issue Aug 2014Pharma Uptoday Monthly Magazine Volume 5, Issue Aug 2014
Pharma Uptoday Monthly Magazine Volume 5, Issue Aug 2014Sathish Vemula
 

Similaire à Fda adverse event reporting requirements for otc drugs (20)

Fda med watch
Fda med watchFda med watch
Fda med watch
 
Health Canada Progressive Licensing - Professor Peivand Pirouzi
Health Canada Progressive Licensing - Professor Peivand PirouziHealth Canada Progressive Licensing - Professor Peivand Pirouzi
Health Canada Progressive Licensing - Professor Peivand Pirouzi
 
Reporting adverse events under COVID-19 to FDA
Reporting adverse events under COVID-19 to FDAReporting adverse events under COVID-19 to FDA
Reporting adverse events under COVID-19 to FDA
 
Medwatch and FAERS database
Medwatch and FAERS databaseMedwatch and FAERS database
Medwatch and FAERS database
 
Ceuta Pharmacovigilance Presentation 2014
Ceuta Pharmacovigilance Presentation 2014Ceuta Pharmacovigilance Presentation 2014
Ceuta Pharmacovigilance Presentation 2014
 
Pharma Uptoday Monthly Magazine - Volume 11, Issue Feb 2015
Pharma Uptoday Monthly Magazine - Volume 11, Issue Feb 2015Pharma Uptoday Monthly Magazine - Volume 11, Issue Feb 2015
Pharma Uptoday Monthly Magazine - Volume 11, Issue Feb 2015
 
Usfda
UsfdaUsfda
Usfda
 
US FDA
US FDA US FDA
US FDA
 
How FSMA Changes The Status Quo For Food Businesses
How FSMA Changes The Status Quo For Food BusinessesHow FSMA Changes The Status Quo For Food Businesses
How FSMA Changes The Status Quo For Food Businesses
 
Pharmaceutical product recall
Pharmaceutical product recallPharmaceutical product recall
Pharmaceutical product recall
 
Spontaneous Reporting System
Spontaneous Reporting SystemSpontaneous Reporting System
Spontaneous Reporting System
 
USFDA
USFDAUSFDA
USFDA
 
Ppt 1 overview of regulatory affairs and diff bodies_august2016_final
Ppt 1 overview of regulatory affairs and diff bodies_august2016_finalPpt 1 overview of regulatory affairs and diff bodies_august2016_final
Ppt 1 overview of regulatory affairs and diff bodies_august2016_final
 
My Presentation on Mexico Medical Device Regulations
My Presentation on Mexico Medical Device RegulationsMy Presentation on Mexico Medical Device Regulations
My Presentation on Mexico Medical Device Regulations
 
Labelling of drugs cosmetics nd biotech
Labelling of drugs cosmetics nd biotechLabelling of drugs cosmetics nd biotech
Labelling of drugs cosmetics nd biotech
 
clinical Research and pharmacovigilance.pptx
clinical Research and pharmacovigilance.pptxclinical Research and pharmacovigilance.pptx
clinical Research and pharmacovigilance.pptx
 
US FDA Regs & Modernization Act 2012
US FDA Regs & Modernization Act 2012US FDA Regs & Modernization Act 2012
US FDA Regs & Modernization Act 2012
 
Pharmacovigilance sytem in United States of America (USA)
Pharmacovigilance sytem in United States of America (USA)Pharmacovigilance sytem in United States of America (USA)
Pharmacovigilance sytem in United States of America (USA)
 
IQ Pharmacovigilance system (updated).pptx
IQ Pharmacovigilance system (updated).pptxIQ Pharmacovigilance system (updated).pptx
IQ Pharmacovigilance system (updated).pptx
 
Pharma Uptoday Monthly Magazine Volume 5, Issue Aug 2014
Pharma Uptoday Monthly Magazine Volume 5, Issue Aug 2014Pharma Uptoday Monthly Magazine Volume 5, Issue Aug 2014
Pharma Uptoday Monthly Magazine Volume 5, Issue Aug 2014
 

Plus de complianceonline123

Social media risks rules policies procedures
Social media risks rules policies  proceduresSocial media risks rules policies  procedures
Social media risks rules policies procedurescomplianceonline123
 
Out in the open protecting your privacy in the digital age
Out in the open  protecting your privacy in the digital ageOut in the open  protecting your privacy in the digital age
Out in the open protecting your privacy in the digital agecomplianceonline123
 
Reaching Clean Power Plan Goals at No Cost: Securing the Smart Grid’s Potential
Reaching Clean Power Plan Goals at No Cost: Securing the Smart Grid’s PotentialReaching Clean Power Plan Goals at No Cost: Securing the Smart Grid’s Potential
Reaching Clean Power Plan Goals at No Cost: Securing the Smart Grid’s Potentialcomplianceonline123
 
Audit Process: How to Successfully Plan Audit
Audit Process: How to Successfully Plan Audit Audit Process: How to Successfully Plan Audit
Audit Process: How to Successfully Plan Audit complianceonline123
 
Aml non bank finanacial institutions
Aml non bank finanacial institutionsAml non bank finanacial institutions
Aml non bank finanacial institutionscomplianceonline123
 
Gdp how to manage documentation lifecycle
Gdp  how to manage documentation lifecycleGdp  how to manage documentation lifecycle
Gdp how to manage documentation lifecyclecomplianceonline123
 
I 9 compliance- how to avoid errors
I 9 compliance- how to avoid errorsI 9 compliance- how to avoid errors
I 9 compliance- how to avoid errorscomplianceonline123
 

Plus de complianceonline123 (20)

Social media risks rules policies procedures
Social media risks rules policies  proceduresSocial media risks rules policies  procedures
Social media risks rules policies procedures
 
Fmla ada overlap
Fmla  ada  overlapFmla  ada  overlap
Fmla ada overlap
 
Hipaa enforcement examples
Hipaa enforcement examplesHipaa enforcement examples
Hipaa enforcement examples
 
Retail loss
Retail lossRetail loss
Retail loss
 
Hipaa privacy rule
Hipaa privacy ruleHipaa privacy rule
Hipaa privacy rule
 
Fda warning letters
Fda  warning lettersFda  warning letters
Fda warning letters
 
Dietary supplement
Dietary supplementDietary supplement
Dietary supplement
 
Out in the open protecting your privacy in the digital age
Out in the open  protecting your privacy in the digital ageOut in the open  protecting your privacy in the digital age
Out in the open protecting your privacy in the digital age
 
Reaching Clean Power Plan Goals at No Cost: Securing the Smart Grid’s Potential
Reaching Clean Power Plan Goals at No Cost: Securing the Smart Grid’s PotentialReaching Clean Power Plan Goals at No Cost: Securing the Smart Grid’s Potential
Reaching Clean Power Plan Goals at No Cost: Securing the Smart Grid’s Potential
 
Audit Process: How to Successfully Plan Audit
Audit Process: How to Successfully Plan Audit Audit Process: How to Successfully Plan Audit
Audit Process: How to Successfully Plan Audit
 
Basics of internal audit
Basics of internal auditBasics of internal audit
Basics of internal audit
 
Free trade zones
Free trade zonesFree trade zones
Free trade zones
 
Sec what you need to know
Sec what you need to knowSec what you need to know
Sec what you need to know
 
Auditing your grc programs
Auditing your grc programsAuditing your grc programs
Auditing your grc programs
 
Aml non bank finanacial institutions
Aml non bank finanacial institutionsAml non bank finanacial institutions
Aml non bank finanacial institutions
 
Gdp how to manage documentation lifecycle
Gdp  how to manage documentation lifecycleGdp  how to manage documentation lifecycle
Gdp how to manage documentation lifecycle
 
Workplace harrasment
Workplace harrasmentWorkplace harrasment
Workplace harrasment
 
Good documentation practices
Good documentation practicesGood documentation practices
Good documentation practices
 
Information security threats
Information security threatsInformation security threats
Information security threats
 
I 9 compliance- how to avoid errors
I 9 compliance- how to avoid errorsI 9 compliance- how to avoid errors
I 9 compliance- how to avoid errors
 

Dernier

Pests of jatropha_Bionomics_identification_Dr.UPR.pdf
Pests of jatropha_Bionomics_identification_Dr.UPR.pdfPests of jatropha_Bionomics_identification_Dr.UPR.pdf
Pests of jatropha_Bionomics_identification_Dr.UPR.pdfPirithiRaju
 
Speech, hearing, noise, intelligibility.pptx
Speech, hearing, noise, intelligibility.pptxSpeech, hearing, noise, intelligibility.pptx
Speech, hearing, noise, intelligibility.pptxpriyankatabhane
 
Radiation physics in Dental Radiology...
Radiation physics in Dental Radiology...Radiation physics in Dental Radiology...
Radiation physics in Dental Radiology...navyadasi1992
 
Pests of safflower_Binomics_Identification_Dr.UPR.pdf
Pests of safflower_Binomics_Identification_Dr.UPR.pdfPests of safflower_Binomics_Identification_Dr.UPR.pdf
Pests of safflower_Binomics_Identification_Dr.UPR.pdfPirithiRaju
 
REVISTA DE BIOLOGIA E CIÊNCIAS DA TERRA ISSN 1519-5228 - Artigo_Bioterra_V24_...
REVISTA DE BIOLOGIA E CIÊNCIAS DA TERRA ISSN 1519-5228 - Artigo_Bioterra_V24_...REVISTA DE BIOLOGIA E CIÊNCIAS DA TERRA ISSN 1519-5228 - Artigo_Bioterra_V24_...
REVISTA DE BIOLOGIA E CIÊNCIAS DA TERRA ISSN 1519-5228 - Artigo_Bioterra_V24_...Universidade Federal de Sergipe - UFS
 
User Guide: Orion™ Weather Station (Columbia Weather Systems)
User Guide: Orion™ Weather Station (Columbia Weather Systems)User Guide: Orion™ Weather Station (Columbia Weather Systems)
User Guide: Orion™ Weather Station (Columbia Weather Systems)Columbia Weather Systems
 
Pests of castor_Binomics_Identification_Dr.UPR.pdf
Pests of castor_Binomics_Identification_Dr.UPR.pdfPests of castor_Binomics_Identification_Dr.UPR.pdf
Pests of castor_Binomics_Identification_Dr.UPR.pdfPirithiRaju
 
(9818099198) Call Girls In Noida Sector 14 (NOIDA ESCORTS)
(9818099198) Call Girls In Noida Sector 14 (NOIDA ESCORTS)(9818099198) Call Girls In Noida Sector 14 (NOIDA ESCORTS)
(9818099198) Call Girls In Noida Sector 14 (NOIDA ESCORTS)riyaescorts54
 
OECD bibliometric indicators: Selected highlights, April 2024
OECD bibliometric indicators: Selected highlights, April 2024OECD bibliometric indicators: Selected highlights, April 2024
OECD bibliometric indicators: Selected highlights, April 2024innovationoecd
 
Pests of soyabean_Binomics_IdentificationDr.UPR.pdf
Pests of soyabean_Binomics_IdentificationDr.UPR.pdfPests of soyabean_Binomics_IdentificationDr.UPR.pdf
Pests of soyabean_Binomics_IdentificationDr.UPR.pdfPirithiRaju
 
LIGHT-PHENOMENA-BY-CABUALDIONALDOPANOGANCADIENTE-CONDEZA (1).pptx
LIGHT-PHENOMENA-BY-CABUALDIONALDOPANOGANCADIENTE-CONDEZA (1).pptxLIGHT-PHENOMENA-BY-CABUALDIONALDOPANOGANCADIENTE-CONDEZA (1).pptx
LIGHT-PHENOMENA-BY-CABUALDIONALDOPANOGANCADIENTE-CONDEZA (1).pptxmalonesandreagweneth
 
The dark energy paradox leads to a new structure of spacetime.pptx
The dark energy paradox leads to a new structure of spacetime.pptxThe dark energy paradox leads to a new structure of spacetime.pptx
The dark energy paradox leads to a new structure of spacetime.pptxEran Akiva Sinbar
 
Bioteknologi kelas 10 kumer smapsa .pptx
Bioteknologi kelas 10 kumer smapsa .pptxBioteknologi kelas 10 kumer smapsa .pptx
Bioteknologi kelas 10 kumer smapsa .pptx023NiWayanAnggiSriWa
 
User Guide: Magellan MX™ Weather Station
User Guide: Magellan MX™ Weather StationUser Guide: Magellan MX™ Weather Station
User Guide: Magellan MX™ Weather StationColumbia Weather Systems
 
《Queensland毕业文凭-昆士兰大学毕业证成绩单》
《Queensland毕业文凭-昆士兰大学毕业证成绩单》《Queensland毕业文凭-昆士兰大学毕业证成绩单》
《Queensland毕业文凭-昆士兰大学毕业证成绩单》rnrncn29
 
Thermodynamics ,types of system,formulae ,gibbs free energy .pptx
Thermodynamics ,types of system,formulae ,gibbs free energy .pptxThermodynamics ,types of system,formulae ,gibbs free energy .pptx
Thermodynamics ,types of system,formulae ,gibbs free energy .pptxuniversity
 
ECG Graph Monitoring with AD8232 ECG Sensor & Arduino.pptx
ECG Graph Monitoring with AD8232 ECG Sensor & Arduino.pptxECG Graph Monitoring with AD8232 ECG Sensor & Arduino.pptx
ECG Graph Monitoring with AD8232 ECG Sensor & Arduino.pptxmaryFF1
 
GenBio2 - Lesson 1 - Introduction to Genetics.pptx
GenBio2 - Lesson 1 - Introduction to Genetics.pptxGenBio2 - Lesson 1 - Introduction to Genetics.pptx
GenBio2 - Lesson 1 - Introduction to Genetics.pptxBerniceCayabyab1
 
User Guide: Capricorn FLX™ Weather Station
User Guide: Capricorn FLX™ Weather StationUser Guide: Capricorn FLX™ Weather Station
User Guide: Capricorn FLX™ Weather StationColumbia Weather Systems
 

Dernier (20)

Pests of jatropha_Bionomics_identification_Dr.UPR.pdf
Pests of jatropha_Bionomics_identification_Dr.UPR.pdfPests of jatropha_Bionomics_identification_Dr.UPR.pdf
Pests of jatropha_Bionomics_identification_Dr.UPR.pdf
 
Speech, hearing, noise, intelligibility.pptx
Speech, hearing, noise, intelligibility.pptxSpeech, hearing, noise, intelligibility.pptx
Speech, hearing, noise, intelligibility.pptx
 
Radiation physics in Dental Radiology...
Radiation physics in Dental Radiology...Radiation physics in Dental Radiology...
Radiation physics in Dental Radiology...
 
Pests of safflower_Binomics_Identification_Dr.UPR.pdf
Pests of safflower_Binomics_Identification_Dr.UPR.pdfPests of safflower_Binomics_Identification_Dr.UPR.pdf
Pests of safflower_Binomics_Identification_Dr.UPR.pdf
 
REVISTA DE BIOLOGIA E CIÊNCIAS DA TERRA ISSN 1519-5228 - Artigo_Bioterra_V24_...
REVISTA DE BIOLOGIA E CIÊNCIAS DA TERRA ISSN 1519-5228 - Artigo_Bioterra_V24_...REVISTA DE BIOLOGIA E CIÊNCIAS DA TERRA ISSN 1519-5228 - Artigo_Bioterra_V24_...
REVISTA DE BIOLOGIA E CIÊNCIAS DA TERRA ISSN 1519-5228 - Artigo_Bioterra_V24_...
 
User Guide: Orion™ Weather Station (Columbia Weather Systems)
User Guide: Orion™ Weather Station (Columbia Weather Systems)User Guide: Orion™ Weather Station (Columbia Weather Systems)
User Guide: Orion™ Weather Station (Columbia Weather Systems)
 
Pests of castor_Binomics_Identification_Dr.UPR.pdf
Pests of castor_Binomics_Identification_Dr.UPR.pdfPests of castor_Binomics_Identification_Dr.UPR.pdf
Pests of castor_Binomics_Identification_Dr.UPR.pdf
 
(9818099198) Call Girls In Noida Sector 14 (NOIDA ESCORTS)
(9818099198) Call Girls In Noida Sector 14 (NOIDA ESCORTS)(9818099198) Call Girls In Noida Sector 14 (NOIDA ESCORTS)
(9818099198) Call Girls In Noida Sector 14 (NOIDA ESCORTS)
 
OECD bibliometric indicators: Selected highlights, April 2024
OECD bibliometric indicators: Selected highlights, April 2024OECD bibliometric indicators: Selected highlights, April 2024
OECD bibliometric indicators: Selected highlights, April 2024
 
Pests of soyabean_Binomics_IdentificationDr.UPR.pdf
Pests of soyabean_Binomics_IdentificationDr.UPR.pdfPests of soyabean_Binomics_IdentificationDr.UPR.pdf
Pests of soyabean_Binomics_IdentificationDr.UPR.pdf
 
LIGHT-PHENOMENA-BY-CABUALDIONALDOPANOGANCADIENTE-CONDEZA (1).pptx
LIGHT-PHENOMENA-BY-CABUALDIONALDOPANOGANCADIENTE-CONDEZA (1).pptxLIGHT-PHENOMENA-BY-CABUALDIONALDOPANOGANCADIENTE-CONDEZA (1).pptx
LIGHT-PHENOMENA-BY-CABUALDIONALDOPANOGANCADIENTE-CONDEZA (1).pptx
 
The dark energy paradox leads to a new structure of spacetime.pptx
The dark energy paradox leads to a new structure of spacetime.pptxThe dark energy paradox leads to a new structure of spacetime.pptx
The dark energy paradox leads to a new structure of spacetime.pptx
 
Bioteknologi kelas 10 kumer smapsa .pptx
Bioteknologi kelas 10 kumer smapsa .pptxBioteknologi kelas 10 kumer smapsa .pptx
Bioteknologi kelas 10 kumer smapsa .pptx
 
User Guide: Magellan MX™ Weather Station
User Guide: Magellan MX™ Weather StationUser Guide: Magellan MX™ Weather Station
User Guide: Magellan MX™ Weather Station
 
《Queensland毕业文凭-昆士兰大学毕业证成绩单》
《Queensland毕业文凭-昆士兰大学毕业证成绩单》《Queensland毕业文凭-昆士兰大学毕业证成绩单》
《Queensland毕业文凭-昆士兰大学毕业证成绩单》
 
Thermodynamics ,types of system,formulae ,gibbs free energy .pptx
Thermodynamics ,types of system,formulae ,gibbs free energy .pptxThermodynamics ,types of system,formulae ,gibbs free energy .pptx
Thermodynamics ,types of system,formulae ,gibbs free energy .pptx
 
ECG Graph Monitoring with AD8232 ECG Sensor & Arduino.pptx
ECG Graph Monitoring with AD8232 ECG Sensor & Arduino.pptxECG Graph Monitoring with AD8232 ECG Sensor & Arduino.pptx
ECG Graph Monitoring with AD8232 ECG Sensor & Arduino.pptx
 
GenBio2 - Lesson 1 - Introduction to Genetics.pptx
GenBio2 - Lesson 1 - Introduction to Genetics.pptxGenBio2 - Lesson 1 - Introduction to Genetics.pptx
GenBio2 - Lesson 1 - Introduction to Genetics.pptx
 
User Guide: Capricorn FLX™ Weather Station
User Guide: Capricorn FLX™ Weather StationUser Guide: Capricorn FLX™ Weather Station
User Guide: Capricorn FLX™ Weather Station
 
Volatile Oils Pharmacognosy And Phytochemistry -I
Volatile Oils Pharmacognosy And Phytochemistry -IVolatile Oils Pharmacognosy And Phytochemistry -I
Volatile Oils Pharmacognosy And Phytochemistry -I
 

Fda adverse event reporting requirements for otc drugs

  • 1. FDA Notificationsand Medwatch Form Requirements Adverse Event Reporting for OTC Drugs and Dietary Supplements
  • 2. The Background– What YouNeedto Know Adverse Event (AE) reporting regulations implement the Dietary Supplement & OTC Drug Consumer Protection Act of 2006 (Public Law 109-462). FDA regulations for adverse event reporting went into effect in December 2007. Product label must contain the address (street address or P.O. Box) or phone number at which company or other responsible person will receive a serious adverse event report. Serious Adverse Event (SAE) reporting is required for all OTC Drugs and Dietary Supplements.
  • 3. Products That Are Covered All OTC monographed drugs (Rx to OTC drugs are already required to report AEs). All dietary supplements including vitamins, minerals, herbal or other botanical products, amino acids, or any dietary substance used to supplement the diet by increasing the total dietary intake. When the Personal Care Products Safety Act becomes law, cosmetics will also be covered.
  • 4. Death: Report if the patient’s death is suspected of being associated with use of the product by the patient. Life-Threatening: Report if the person was at substantial risk of dying at time of the adverse event or if suspected that continued use of product could result in a person’s death. Hospitalization: Report if admission to the hospital was caused by or related to an adverse event associated with use of the product. Emergency Room treatment is sometimes reported too. Disability: Report if the adverse event resulted in a significant or permanent change, impairment or damage to the person’s body function/structure or quality of life. Spontaneous abortion, congenital anomaly or birth defect associated with a product use must also be reported to the FDA. Definition of a Serious Adverse Event (SAE) Section 761(a)(2) of the F,D, & C Act
  • 5. FDA Notifications- Voluntary SAE Reporting FDA encourages healthcare professionals to report serious adverse events to the agency for tracking purposes. FDA’s Center for Food Safety & Applied Nutrition (CFSAN) Adverse Event Reporting System (CAERS) collects reports about adverse events and product complaints related to CFSAN regulated products, including foods, dietary supplements and cosmetics. CFSAN encourages voluntary AE reports for cosmetics and conventional foods. If a company receives a report of a serious adverse event, you should report it to CAERS even if reporting isn’t mandatory for the product (e.g. a food or cosmetic).
  • 6. FDA Notifications Many serious adverse events are reported to FDA directly by consumers, hospitals, or healthcare professionals. If FDA receives a serious adverse event report about a company’s product they will contact you and you must keep that report on file. Often FDA notification comes with a request for more information and submission of a Medwatch form with product label.
  • 7. MedwatchFormRequirements(Form 3500A) Medwatch form must identify the injured person (name, age, sex, full address, etc.). Initials are used to protect privacy. An identifiable initial reporter of the event. Identity and contact information for the responsible party (i.e. the manufacturer, packer, or distributor representative submitting the AE report to FDA). Name of the specific product that is suspected of causing the adverse event (not just a brand name). Description of the serious adverse event with outcome.
  • 8. Address for MedwatchFormHard Copy Submission DIETARY SUPPLEMENTS: FAX NUMBER FOR ALL AEs: 1 800 332 - 0178 FDA Center Food Safety & Nutrition Office of Food Defense, HFS -11 5100 Paint Brach Parkway College Park, MD. 20740 OTC DRUGS: FDA Center Drug Evaluation & Research Central Document Room 5901-B Ammendale Road Beltsville, MD. 20705-1266
  • 9. Online Reportingof MedwatchForms Or http://www.fda.gov/Safety/MedWatch/default.htm Go to the FDA website (www.fda.gov), click on “Drugs” and enter “MEDWATCH form”. Click on “Download form” or click on “Recalls & Alerts” and see bullet called “MEDWATCH.” Click on “Report serious adverse events online.”